Suppr超能文献

高车前苷载药 TPGs/mPEG-PDLLA 自组装聚合物胶束的制备、表征及评价。

Hyperoside-loaded TPGs/mPEG-PDLLA self-assembled polymeric micelles: preparation, characterization and / evaluation.

机构信息

College of Pharmacy, Jiangsu University, Zhenjiang, China.

Department of Biochemistry and Forensic Sciences, School of Chemical and Biochemical Sciences, C. K. Tedam University of Technology and Applied Sciences (CKT-UTAS), Navrongo, Ghana.

出版信息

Pharm Dev Technol. 2022 Sep;27(7):829-841. doi: 10.1080/10837450.2022.2122506. Epub 2022 Sep 13.

Abstract

Hyperoside (Hyp) self-assembled polymeric micelles (Hyp-PMs) were purposely developed to enhance aqueous solubility, availability and anti-oxidative effect of Hyp. In preparing Hyp-PMs, we employed the thin film dispersion method with the micelles consisting of TPGs and mPEG2000-PDLLA3000. The particle size, polydispersity index and zeta potential of Hyp-PMs were 67.42 ± 1.44 nm, 0.229 ± 0.015 and -18.67 ± 0.576 mV, respectively, coupled with high encapsulation efficiency (EE)of 90.63 ± 1.45% and drug loading (DL) of 6.97 ± 1.56%. Furthermore, the value of critical micelle concentration (CMC) was quite low, which indicated good stability and improved self-assembly ability of Hyp-PMs. Also, trend of Hyp release from Hyp-PMs demonstrated enhanced solubility of Hyp. Similarly, in comparison with free Hyp, oral bioavailability of Hyp-PMs was improved (about 8 folds) whilst half-life of Hyp-PMs was extended (about 3 folds). anti-oxidative effect showed obvious strong scavenging DPPH capability of Hyp-PMs, which may be attributed to its smaller size and better solubility. Altogether, Hyp-PMs may serve as a possible strategy to potentially enhance aqueous solubility, bioavailability and anti-oxidative effect of Hyp, which may play a key role in Hyp application in the pharmaceutical industries.

摘要

目的在于提高 Hyp 的水溶性、生物利用度和抗氧化效果,我们专门开发了 Hyp 自组装聚合物胶束(Hyp-PMs)。在制备 Hyp-PMs 时,我们采用薄膜分散法,胶束由 TPGs 和 mPEG2000-PDLLA3000 组成。Hyp-PMs 的粒径、多分散指数和 Zeta 电位分别为 67.42±1.44nm、0.229±0.015 和-18.67±0.576mV,包封效率(EE)高达 90.63±1.45%,载药量(DL)为 6.97±1.56%。此外,临界胶束浓度(CMC)值相当低,表明 Hyp-PMs 具有良好的稳定性和自组装能力。同样,Hyp 从 Hyp-PMs 中的释放趋势表明 Hyp 的溶解度提高。同样,与游离 Hyp 相比,Hyp-PMs 的口服生物利用度提高(约 8 倍),半衰期延长(约 3 倍)。Hyp-PMs 具有明显的强清除 DPPH 能力,这可能归因于其较小的尺寸和更好的溶解度。总的来说,Hyp-PMs 可能是一种提高 Hyp 水溶性、生物利用度和抗氧化效果的潜在策略,这可能在 Hyp 在制药行业的应用中发挥关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验